Amarin Corp Plc (AMRN)

[Will Lar]

GIA!

Amarin is a single drug company without R&D, pipeline, manufacturer facilities & capabilities. Even its clinical research and trials are largely contracted out. The only assets that it has are labeling (the most valuable one), patent portfolio (oops!) and supplier contracts (value pending the terms). And if you want, let's throw the workforce (including all the newbie salespeople) to the pile. That's it!

And it's trying to tackle a VERY mature market - CVD, crowded with many options and dominated by the biggest of the big pharmas.

GIA in this case is like taking a knife to a gun fight. Seriously?!